Consumer electronics retailer Best Buy to shut operations in Mexico

Consumer electronics retailer Best Buy to shut operations in Mexico

Date: 2020-11-27 By Saipriya Iyer

Best Buy, a leading American consumer electronics retailer, has reportedly decided to shut all its operations in Mexico. The move was announced after the firm’s Chief Executive Officer, Corie Barry revealed the firm’s decision t....

13 countries in Africa unite to find a potential COVID-19 treatment

Thirteen African nations have joined hands with researchers across the world to rollout the largest clinical study of potential coronavirus treatments on the African continent. The trial, dubbed the Anticov study, involves contributions fr....

Cleveland Clinic & Anixa submit IND for their breast cancer vaccine

Anixa Biosciences, Inc., a renowned biotechnology firm primarily focused on the prevention and treatment of cancer as well as other infectious diseases, has reportedly announced that a new IND application for the company’s innovative ....

Sydney University researchers to get $1.12 million for vaccine testing

Researchers at the University of Sydney have reportedly been rewarded over $1.12 million as funding from the IMCRC (Innovative Manufacturing CRC) to conduct independent clinical research tests to assess the efficacy of needle-free vaccinati....

Target and Kohl’s to sell beauty products as department stores reel

Some retailers are speculating that eye shadow palettes, facial scrubs, and lip glosses will likely be the upcoming popular thing that would bring significant customer attention, especially the younger generation, to their stores. As the l....

Supemtek® influenza vaccine gains approval in European Union

The European Commission has recently approved the authorization for commercialization of Supemtek®, a quadrivalent recombinant technology-based influenza vaccine, designed for preventing influenza among adults in the age group of 18 yea....

U.S. FDA approves adjunctive therapy & intravenous use of VIMPAT®

UCB, a biopharmaceutical company, has recently gained the approval of the U.S. FDA (Food & Drug Administration) for its prescription medicine, VIMPAT®. VIMPAT® (lacosamide) CV will now be used as an adjunctive therapy for the t....

Industry Updates